MRVI
NASDAQ
US
Maravai LifeSciences Holdings, Inc. - Class A common stock
$2.95
▲ +$0.08
(+2.79%)
Vol 1.8M
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$831.0M
ROE
-42.6%
Margin
-63.1%
D/E
132.07
Beta
0.36
52W
$2–$6
Wall Street Consensus
17 analysts · Apr 20264
Strong Buy
6
Buy
7
Hold
0
Sell
0
Strong Sell
58.8%
Buy Rating
Price Chart
Similar Stocks
FTRE
Fortrea Holdings Inc
$1.6B
PSNL
Personalis Inc
$706.9M
CTKB
Cytek Biosciences Inc
$645.7M
MLAB
Mesa Laboratories Inc
$433.5M
CYRX
Cryoport Inc
P/E 7.1
$480.7M
NAUT
Nautilus Biotechnology Inc
$246.3M
PACB
Pacific Biosciences of California Inc
$564.6M
LAB
Standard BioTools Inc
$492.2M
OABI
OmniAb Inc
$266.3M
ATLN
Atlantic International Corp
$77.8M
Earnings
Beat rate: 50.0%
Next Report
May 11, 2026
EPS Estimate: $-0.05
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.05 | — | — |
| Dec 2025 | $-0.07 | $-0.04 | +$0.03 |
| Sep 2025 | $-0.08 | $-0.08 | +$0.00 |
| Jun 2025 | $-0.07 | $-0.08 | $-0.01 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -63.0% | -63.0% | -63.0% | -63.0% | -42.6% | -42.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -83.5% | -90.2% | -90.2% | -90.2% | -63.0% | -63.0% |
| Gross Margin | 16.4% | 29.1% | 29.1% | 29.1% | 20.9% | 20.9% |
| D/E Ratio | 122.40 | 122.40 | 122.40 | 122.40 | 132.07 | 132.07 |
| Current Ratio | 5.16 | 5.16 | 5.16 | 5.16 | 5.29 | 5.29 |
Key Ratios
ROA (TTM)
-13.1%
P/S (TTM)
4.32
P/B
4.2
EPS (TTM)
$-0.84
CF/Share
$0.75
Rev Growth 3Y
-31.3%
52W High
$6.21
52W Low
$1.67
$1.67
52-Week Range
$6.21
How does MRVI compare to Life Sciences Tools & Services peers?
Peer group: Small-cap Life Sciences Tools & Services ($300M+) · 25 companies
MRVI valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Fair value
P/S ratio
4.3
▲
13%
above
peers
(3.8)
vs Peers
vs Industry
Fair value
P/B ratio
4.2
▲
13%
above
peers
(3.7)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
MRVI profitability vs Life Sciences Tools & Services peers
ROE
-42.6%
▼
1204%
below
peers
(-3.3%)
vs Peers
vs Industry
Weak
Net margin
-63.1%
▼
571%
below
peers
(-9.4%)
vs Peers
vs Industry
Weak
Gross margin
20.9%
▼
57%
below
peers
(48.0%)
vs Peers
vs Industry
Weak
ROA
-13.1%
▼
402%
below
peers
(-2.6%)
vs Peers
vs Industry
Weak
MRVI financial health vs Life Sciences Tools & Services peers
D/E ratio
132.1
▲
262%
above
peers
(36.5)
vs Peers
vs Industry
High debt
Current ratio
5.3
▲
57%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.4
▼
74%
below
peers
(1.4)
vs Peers
vs Industry
More volatile
MRVI fundamentals radar
MRVI
Peer median
Industry
MRVI profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
MRVI vs peers: key metrics
Latest News
No related news yet